This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Chronic Obstructive Pulmonary Disease
and you are
over 40
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

Phase I study to evaluate the safety and tolerability of single ascending intravenous doses of MEDI2338 in subjects with stable, mild to moderate chronic obstructive pulmonary disease (COPD).

Provided treatments

  • Biological: MEDI2338
  • Biological: MEDI2338
  • Biological: MEDI2338
  • Biological: MEDI2338
  • Biological: MEDI2338
  • Other: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01322594. The sponsor of the trial is MedImmune LLC and it is looking for 31 volunteers for the current phase.
Official trial title:
A Phase 1, Single Ascending Dose Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease